Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

340
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
340
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

662
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
662
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

315
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
315
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

2.2K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying hepatocellular carcinoma patients at risk of early non-response after first-cycle transarterial chemoembolization: A reproducible machine learning study.

Clinical imaging·2026
Same author

Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.

Future oncology (London, England)·2026
Same author

Antiviral Potential of Onosma bracteata Against Chikungunya Virus: Experimental Validation and Computational Mechanistic Study.

Applied biochemistry and biotechnology·2026
Same author

Retrospective analysis for skydiving injuries: A high-volume single-site case series.

Trauma case reports·2026
Same author

Prevalence, adherence, and health care resource utilization in schizophrenia: A national and state-level analysis of US Medicaid Beneficiaries.

Journal of managed care & specialty pharmacy·2026
Same author

RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma.

Blood cancer discovery·2026

Related Experiment Video

Updated: Aug 27, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Continuous Glucose Monitoring: An Opportunity for Population-Based Diabetes Management.

Alexis Skoufalos1, Roy Thomas2, Ravi Patel3

  • 1Jefferson College of Population Health, Philadelphia, Pennsylvania, USA.

Population Health Management
|September 26, 2022
PubMed
Summary

Real-time continuous glucose monitoring (rtCGM) helps manage diabetes by providing constant glucose readings without fingersticks. This technology aids in controlling blood sugar levels and understanding lifestyle impacts, supporting better health outcomes.

Keywords:
behavior modification supportcontinuous glucose monitoringdiabetes managementpopulation-based diabetes management

More Related Videos

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

5.8K
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

744

Related Experiment Videos

Last Updated: Aug 27, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

5.8K
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

744

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Medical Technology

Background:

  • Rising prevalence of prediabetes and diabetes in the US presents a significant public health challenge.
  • Diabetes management requires frequent glucose monitoring, traditionally via fingersticks.
  • Associated conditions include obesity, hypertension, dyslipidemia, and cardiovascular disease.

Purpose of the Study:

  • To evaluate the role of real-time continuous glucose monitoring (rtCGM) in diabetes management.
  • To assess the effectiveness of rtCGM in improving glucose control and patient understanding of lifestyle impacts.
  • To explore the integration of rtCGM into population-level diabetes management programs.

Main Methods:

  • Review of accruing evidence on rtCGM effectiveness.
  • Analysis of payer organization adoption of rtCGM in diabetes management programs.
  • Consideration of integrated programmatic approaches for chronic disease management.

Main Results:

  • rtCGM provides continuous glucose measurements without fingersticks.
  • Evidence indicates rtCGM is effective for managing diabetes and understanding lifestyle influences on glucose levels.
  • Payer organizations are increasingly incorporating rtCGM into diabetes management.

Conclusions:

  • rtCGM is a valuable tool for patients and clinicians in managing diabetes.
  • Integrating rtCGM into population health programs may improve quality outcomes and reduce costs.
  • Broader adoption and continued study of rtCGM integration models are supported by current evidence.